marketcap
Facebook
Twitter
Telegram
Fehler meldenQuartalsbericht 2024-Q3
hinzugefügt 14.11.2024
Forte Biosciences Bilanz 2011-2024 | FBRX
Bilanz Jährlich Forte Biosciences
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nettoverschuldung |
- | - | - | -58.8 M | -2.19 M | -14.6 M | -25.1 M | 15.5 M | 9.5 M | - | - | - | - |
Langfristige Schulden |
- | - | - | - | - | 26.2 M | 3.62 M | 13.8 M | 17 M | - | - | - | - |
Langfristiger Schuldenstrom |
- | - | - | - | 416 K | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | - | 10.5 M | 28.4 M | 3.66 M | 14 M | 17.2 M | - | - | - | - |
Kurzfristige Verbindlichkeiten |
3.67 M | 3.18 M | 1.76 M | 2.26 M | 13.2 M | 16.5 M | 17.3 M | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
- | - | - | 2.26 M | 12.4 M | 44.9 M | 21 M | 28.4 M | 23.1 M | - | - | - | - |
Aufgeschobenes Einkommen |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-119 M | -87 M | -73.2 M | -51.5 M | -4.97 M | -216 M | -167 M | -128 M | -94.5 M | - | - | - | - |
Vermögenswerte |
39 M | 42 M | 43.3 M | 61.2 M | 7.66 M | 103 M | 92.1 M | 35.4 M | 62.2 M | - | - | - | - |
Zahlungsmittel |
37.1 M | 41.1 M | 42 M | 58.8 M | 8.99 M | 40.8 M | 35.9 M | 5.51 M | 8.15 M | - | - | - | - |
Buchwert |
39 M | 42 M | 43.3 M | 59 M | -4.77 M | 58.1 M | 71.1 M | 7 M | 39.1 M | - | - | - | - |
Gesamtes Eigenkapital |
35.3 M | 38.8 M | 41.5 M | 59 M | -4.77 M | 58.1 M | 71.1 M | -124 M | -92.3 M | - | - | - | - |
Alle Zahlen in USD-Währung
Bilanz Vierteljährlich Forte Biosciences
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Langfristige Schulden |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.91 M | 4.03 M | 9.12 M | 22.1 M | 24.1 M | 26.2 M | 26.2 M | 26.2 M | 26.2 M | 3.62 M | 3.62 M | 3.62 M | 3.62 M | 10.2 M | 10.2 M | 10.2 M | 10.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 16.6 M | 17.3 M | 50.9 M | 48.7 M | 49.9 M | 44.9 M | 44.9 M | 44.9 M | 44.9 M | 21 M | 21 M | 21 M | 21 M | 28.4 M | 28.4 M | 28.4 M | 28.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 9 K | 18 K | 27 K | 36 K | 36 K | 36 K | 36 K | 36 K | 36 K | 36 K | 36 K | 45 K | 45 K | 45 K | 45 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-147 M | -138 M | -126 M | -119 M | -113 M | -103 M | -93.8 M | -87 M | -82.2 M | -78.8 M | -75.7 M | -73.2 M | -69.8 M | -62.1 M | -56.3 M | -51.5 M | -51.5 M | -51.5 M | -51.5 M | -4.97 M | -4.97 M | -4.97 M | -279 M | -216 M | -216 M | -216 M | -216 M | -167 M | -167 M | -167 M | -167 M | -128 M | -128 M | -128 M | -128 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Vermögenswerte |
17.9 M | 26.1 M | 32 M | 39 M | 47.9 M | 31.2 M | 36.7 M | 42 M | 45.1 M | 39.7 M | 41.3 M | 43.3 M | 47.4 M | 52.9 M | 57.1 M | 61.2 M | 61.2 M | 61.2 M | 61.2 M | 7.66 M | 7.66 M | 7.66 M | 28.2 M | 103 M | 103 M | 103 M | 103 M | 92.1 M | 92.1 M | 92.1 M | 92.1 M | 35.4 M | 35.4 M | 35.4 M | 35.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Zahlungsmittel |
16.4 M | 24.5 M | 30.4 M | 37.1 M | 46.2 M | 20.4 M | 35.9 M | 41.1 M | 44 M | 38.5 M | 40 M | 42 M | 45.7 M | 50.8 M | 54.8 M | 58.8 M | 58.8 M | 58.8 M | 58.8 M | 6.94 M | 6.94 M | 6.94 M | 8.99 M | 40.8 M | 40.8 M | 40.8 M | 40.8 M | 35.9 M | 35.9 M | 35.9 M | 35.9 M | 5.51 M | 5.51 M | 5.51 M | 5.51 M | 8.15 M | - | - | - | 4.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Buchwert |
- | - | - | - | - | - | - | 42 M | 45.1 M | 39.7 M | 41.3 M | 43.3 M | 47.4 M | 52.9 M | 57.1 M | 61.2 M | 61.2 M | 61.2 M | 44.7 M | -9.65 M | -43.3 M | -41.1 M | -21.7 M | 58.1 M | 58.1 M | 58.1 M | 58.1 M | 71.1 M | 71.1 M | 71.1 M | 71.1 M | 7 M | 7 M | 7 M | 7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtes Eigenkapital |
9.37 M | 17 M | 28.7 M | 35.3 M | 40.4 M | 24.9 M | 32.9 M | 38.8 M | 42.8 M | 38.2 M | 40 M | 41.5 M | 43.6 M | 49.9 M | 54.7 M | 59 M | 59 M | 59 M | 59 M | -4.77 M | -4.77 M | -4.77 M | 10.8 M | -736 K | 58.1 M | 58.1 M | 58.1 M | 71.1 M | 71.1 M | 71.1 M | 71.1 M | -124 M | -124 M | -124 M | -124 M | -92.3 M | - | - | - | -70.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung